arrow
A

Antoine Nkuba-Ndaye

cliniques universitaires de kinshasa
H指数:12
被引数:671

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Environmental Surveillance of Poliovirus in the Democratic Republic of the Congo: Sensitivity and Site Productivity, 2017–2025

刚果民主共和国脊髓灰质病毒环境监测:灵敏度与监测点生产力,2017-2025

2026-09-100
OA
Validation of a Bayesian Ebola Diagnostic Model Using Data from the Tenth Epidemic of 2018 to 2020 in the Democratic Republic of Congo

使用刚果民主共和国2018年至2020年第十次埃博拉疫情数据验证贝叶斯埃博拉诊断模型

2026-09-030
OA
Mpox seroprevalence in general population groups in South-Kivu, Democratic Republic of the Congo: a comparative description before and during the clade Ib outbreak

南基伍省一般人群中猴痘血清流行率:在分支Ib疫情前后及期间的比较描述

2026-04-270
OA
Clade Ib Mpox in the Democratic Republic of the Congo (DRC): Clinical and Virological Report of the First Case in Kinshasa, the Capital City

刚果民主共和国(DRC)的Ib支系猴痘:金沙萨首都首例病例的临床与病毒学报告

2025-09-300
OAAI
Corrigendum to “Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC” [Vaccine 62 (2025) 127537]

勘误:致“刚果民主共和国rVSV-ZEBOV疫苗接种后埃博拉病毒和疫苗载体的长期抗体反应”[Vaccine 62 (2025) 127537]

Vaccine
IF3.5
2025-09-170
PRE
Long-term Sequelae in Ebola Virus Disease Survivors Receiving Anti-Ebola Virus Therapies in the Democratic Republic of the Congo: A Prospective Cohort Study

在刚果民主共和国接受抗埃博拉病毒治疗的患者中,埃博拉病毒病幸存者的长期后遗症:一项前瞻性队列研究

2025-08-010
OAAI
Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC

刚果民主共和国接种rVSV-ZEBOV疫苗后对埃博拉病毒和疫苗载体的长期抗体应答

Vaccine
IF3.5
2025-07-230
PRE
Seroprevalence of dengue in the Democratic Republic of Congo, Ghana and Senegal: results of the SERODEN study

刚果民主共和国、加纳和塞内加尔登革热血清流行率:SERODEN研究的结果

2025-03-010
OAAI
Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024
2024-09-190
OAAI
Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study
2024-03-011
PRE
Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report
2024-02-230
OAAI
Use of Mpox Multiplex Serology in the Identification of Cases and Outbreak Investigations in the Democratic Republic of the Congo (DRC)
2023-07-077
OAAI
Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context
2022-02-186
OAAI
A Multidisciplinary Investigation of the First Chikungunya Virus Outbreak in Matadi in the Democratic Republic of the Congo
2021-10-039
OAAI
High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey
2021-06-0534
OAAI
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

系统性埃博拉病毒疾病复发引发的埃博拉病毒传播

2021-04-0164
OAAI
Molecular characterization of chikungunya virus during the 2019 outbreak in the Democratic Republic of the Congo

刚果民主共和国2019暴发期间基孔肯雅病毒的分子特征

2020-09-0214
OAAI
Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa

节食和食虫蝙蝠物种中冠状病毒的多样性: 西非几内亚的一项试点研究

2020-08-0521
OAAI